drug
RM-718
Phase 2updated 6mo agoby $RYTM RHYTHM PHARMACEUTICALS, INC.
Phase 2community read0 votes
indications
indications
Obesity
all catalysts(0)
nothing on the calendar yet
Trials studying RM-718
News(1)
- Coveted metabolic gem Rhythm reportedly gets $10B offer from AstraZenecaAstraZeneca has apparently made a $10 billion bid to acquire Rhythm Pharmaceuticals, an offer William Blair suspects will not be the last for the hot ticket metabolic biotech.biospace · 14d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that